TABLE 3.

Treatment received by each patient

				Cloned cells administered (×10−9)
Patient	Cy*	Flu†	IL-2‡	Source	First cycle	Second cycle
1	30	25	—	TIL	22.4	10.4
2	30	25	—	PBL	21.5	16.0
3	30	25	—	PBL	15.0	14.5
4	60	25	—	TIL	9.3	11.0
5	60	25	—	TIL	4.1	6.0
6	60	25	—	PBL	5.5	nd§
7	60	25	72,000	PBL	11.0	11.0
8	60	25	72,000	TIL	6.8	7.3
9	60	25	72,000	PBL	3.2	1.8
10	60	25	720,000	PBL	2.8	5.6||
11	60	25	720,000	TIL	11.3	14.0
12	60	25	720,000	PBL	0.9	nd§
13	60	25	720,000	PBL	4.9	6.7
14	60	25	720,000	PBL	12.6	nd¶
15	60	25	720,000	PBL	24.2	nd¶

^*Cytoxan (mg/kg)

^†Fludarabine (mg/m²)

^‡Interleukin-2 (IU/kg)

^§Not done: Patient 6 and Patient 12 received only one infusion of cells due to rapid disease progression.

^||Patient 10 received a mixture of three CD8+ T-cell clones in the second infusion cycle with a total cell number of 5.6 × 10⁹ cells.

^¶Not done: Patient 14 and Patient 15 received only one infusion of cloned cells, then they were transferred to other treatment protocols.